グルコース監視システムのアジア太平洋市場

Inkwood Researchが発行した調査報告書(INKW709070)
◆英語タイトル:Asia Pacific Glucose Monitoring System (CGMS & SMBG) Market Forecast 2017-2025
◆商品コード:INKW709070
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2017年8月16日
◆ページ数:82
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アジア太平洋
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD2,000 ⇒換算¥226,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

KEY FINDINGS Asia-Pacific CGMS Market is growing at a CAGR of 48.72% and the SMBG Market is anticipated to hit $1544 million in the year 2025 with 11.22% of CAGR. The deliberated base year for the market analysis is 2016 and the forecasting period of the glucose monitoring system market is 2017-2025. The diverse factors leading to the GMS market are an augmented increase in the number of people suffering from diabetes, authorization of artificial pancreas, greater awareness, and improved healthcare infrastructure and ease of using CGMS devices.
MARKET INSIGHTS
The glucose monitoring system market is bifurcated into continuous glucose monitoring system and self-monitoring of blood glucose.The CGMS market is segmented by application, component type. There are diverse component types that include the transmitters and receivers, and the sensors. The Sensors are further segmented on the basis of holter type retrospective sensors, insulin pumps, noninvasive glucose sensors, minimally invasive glucose sensors and real-time sensors. The glucose monitors applications include homes, hospitals, diagnostics, and clinics. The SMBG market is segmented into component type, application. The component type market comprises of test strips, glucose meter, and others. The market by application is divided into home settings, hospitals, and clinics. High costing of continuous glucose monitoring systems, deficient reimbursement options, and stringent regulatory norms are the factors that are likely to restrain the market growth. The countries mentioned in the GMS Asia-Pacific market are India, China, Australia and rest of the Asia-Pacific.
COMPETITIVE INSIGHTS
Major giants of the GMS market are Insulet Corporation, Medtronic Inc, Abbott Laboratories, Glysens Inc., Bayer AG Roche, Animas Corporation, Dexcom Inc., Novo Nordisk, and Ypsomed AG.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET
1.3. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.2. BOTTOM-UP APPROACH
2.3. TOP DOWN APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY & KEY FINDINGS
4. MARKET OVERVIEW
4.1. DRIVERS AND IMPACT
4.1.1. INCREASE IN DIABETIC POPULATION
4.1.2. INCREASE IN HEALTHCARE EXPENDITURE
4.1.3. INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
4.1.4. TECHNOLOGY INTEGRATION
4.1.5. INCREASING CGMS AFFORDABILITY
4.1.6. LOW PRICE OF TECHNOLOGY
4.2. RESTRAIN AND IMPACT
4.2.1. HINDERANCE FROM GOVERNMENT REGULATIONS
4.2.2. SMBG MANUFACTURERS RESTRAINING CGMS GROWTH
4.2.3. INADEQUATE REIMBURSEMENT OPTIONS FOR CGM
4.2.4. LACK OF KNOWLEDGE
4.3. KEY TRENDS
4.3.1. DEVELOPMENT OF HIGH-QUALITY WEARABLE DEVICES
4.3.2. MOBILE HEALTHCARE MAKING THE DEVICES MORE USER-FRIENDLY
4.3.3. INCREASING EFFORTS TOWARDS SPREAD OF AWARENESS
4.3.4. INCREASE IN NON-INVASIVE DEVICES
4.3.5. ENERGY HARVESTING TECHNOLOGY FOR UNINTERRUPTED USAGE
5. CGMS MARKET BY COMPONENT TYPE
5.1. SENSORS
5.2. TRANSMITTERS AND RECEIVERS
5.3. INSULIN PUMP
6. CGMS MARKET BY APPLICATION
6.1. HOME SETTINGS
6.2. DIAGNOSTICS AND CLINICS
6.3. HOSPITALS
7. SMBG MARKET
8. SMBG MARKET BY COMPONENT TYPE
8.1. TEST STRIPS
8.2. GLUCOSE METER
8.3. OTHERS
9. SMBG MARKET BY APPLICATION
9.1. HOME SETTINGS
9.2. CLINICS
9.3. HOSPITALS
10. KEY ANALYTICAL
10.1. 5 FORCES ANALYSIS
10.1.1. THREAT OF NEW ENTRANT
10.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
10.1.3. BARGAINING POWER OF BUYERS
10.1.4. BARGAINING POWER OF SUPPLIER
10.1.5. INTENSITY OF COMPETITIVE RIVALRY
10.2. TOP THREE GEOGRAPHIES
10.3. MERGER AND ACQUISITIONS
11. REGIONAL ANALYSIS
11.1. ASIA-PACIFIC (APAC)
11.1.1. CHINA
11.1.2. INDIA
11.1.3. AUSTRALIA
11.1.4. REST OF ASIA-PACIFIC (ROAP)
12. COMPETITIVE LANDSCAPES
12.1. INTRODUCTION
12.2. MEDTRONIC
12.2.1. BUSINESS PROFILE
12.2.2. PRODUCT PORTFOLIO
12.2.3. REVENUE ANALYSIS
12.2.4. STRATEGIC INPUTS
12.2.5. SCOT ANALYSIS
12.3. DEXCOM
12.3.1. BUSINESS PROFILE
12.3.2. PRODUCT PORTFOLIO
12.3.3. REVENUE ANALYSIS
12.3.4. STRATEGIC INPUTS
12.3.5. SCOT ANALYSIS
12.4. ABBOTT
12.4.1. BUSINESS PROFILE
12.4.2. PRODUCT PORTFOLIO
12.4.3. REVENUE ANALYSIS
12.4.4. STRATEGIC INPUTS
12.4.5. SCOT ANALYSIS
12.5. JOHNSON AND JOHNSON
12.5.1. BUSINESS PROFILE
12.5.2. PRODUCT PORTFOLIO
12.5.3. REVENUE ANALYSIS
12.5.4. STRATEGIC INPUTS
12.5.5. SCOT ANALYSIS
12.6. INSULET CORP
12.6.1. BUSINESS PROFILE
12.6.2. PRODUCT PORTFOLIO
12.6.3. REVENUE ANALYSIS
12.6.4. STRATEGIC INPUTS
12.6.5. SCOT ANALYSIS
12.7. TANDEM DIABETES CARE
12.7.1. BUSINESS PROFILE
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. STRATEGIES INPUTS
12.7.5. SCOT ANALYSIS
12.8. ECHO THERAPEUTICS INC
12.8.1. BUSINESS PROFILE
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. STRATEGIES INPUTS
12.8.5. SCOT ANALYSIS
12.9. ROCHE DIAGNOSTICS
12.9.1. BUSINESS PROFILE
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. STRATEGIES INPUTS
12.9.5. SCOT ANALYSIS
12.10. NEMAURA MEDICAL INC
12.10.1. BUSINESS PROFILE
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO
12.10.4. STRATEGIES INPUTS
12.10.5. SCOT ANALYSIS
12.11. SENSEONICS INC
12.11.1. BUSINESS PROFILE
12.11.2. REVENUE ANALYSIS
12.11.3. PRODUCT PORTFOLIO
12.11.4. STRATEGIES INPUTS
12.11.5. SCOT ANALYSIS
12.12. GLYSENS INC
12.12.1. BUSINESS PROFILE
12.12.2. STRATEGIES INPUTS
12.12.3. PRODUCT PORTFOLIO
12.12.4. SCOT ANALYSIS

LIST OF TABLES
TABLE 1 ASIA PACIFIC CGMS MARKET 2017-2025(IN US$ MILLION)
TABLE 2 ASIA PACIFIC SMBG MARKET 2017-2025 (IN US$ MILLION)
TABLE 3 ASIA PACIFIC CGMS MARKET, BY COMPONENT TYPE, 2017-2025(IN US$ MILLION)
TABLE 4 ASIA PACIFIC CGMS SENSORS MARKET, 2017-2025(IN US$ MILLION)
TABLE 5 ASIA PACIFIC CGMS TRANSMITTERS AND RECEIVERS MARKET, 2017-2025(IN US$ MILLION)
TABLE 6 ASIA PACIFIC CGMS INSULIN PUMP MARKET, 2017-2025(IN US$ MILLION)
TABLE 7 ASIA PACIFIC CGMS MARKET, BY APPLICATION 2017-2025 (IN US$ MILLION)
TABLE 8 ASIA PACIFIC CGMS HOME SETTINGS MARKET, 2017-2025(IN US$ MILLION)
TABLE 9 ASIA PACIFIC CGMS DIAGNOSTICS AND CLINICAL MARKET, 2017-2025(IN US$ MILLION)
TABLE 10 ASIA PACIFIC CGMS HOSPITALS MARKET, 2017-2025(IN US$ MILLION)
TABLE 11 IMPORTANT ASPECTS FOR USE OF SMBG DEVICES IN HOME-CARE SETTINGS
TABLE 12 PRODUCT MATRIXES FOR LANCETS
TABLE 13 ASIA PACIFIC SMBG MARKET, BY COMPONENT TYPE, 2017-2025 (IN US$ MILLION)
TABLE 14 ASIA PACIFIC SMBG MARKET 2017-2025 ($ MILLION)
TABLE 15 ASIA PACIFIC CGMS MARKET REVENUE, 2017-2025(IN US$ MILLION)
TABLE 16 ASIA PACIFIC SMBG MARKET REVENUE, 2017-2025(IN US$ MILLION)

LIST OF FIGURES
FIGURE 1 ASIA PACIFIC CGMS MARKET SHARE, BY COMPONENT TYPE 2016 & 2025 (%)
FIGURE 2 ASIA PACIFIC CGMS SENSORS MARKET, 2017-2025(IN US$ MILLION)
FIGURE 3 ASIA PACIFIC CGMS TRANSMITTERS AND RECEIVERS MARKET, 2017-2025(IN US$ MILLION)
FIGURE 4 ASIA PACIFIC CGMS INSULIN PUMP MARKET, 2017-2025(IN US$ MILLION)
FIGURE 5 ASIA PACIFIC CGMS MARKET SHARE, BY APPLICATION 2016 & 2025(%)
FIGURE 6 ASIA PACIFIC CGMS HOME SETTING MARKET, 2017-2025(IN US$ MILLION)
FIGURE 7 ASIA PACIFIC CGMS DIAGNOSTICS AND CLINICAL MARKET, 2017-2025(IN US$ MILLION)
FIGURE 8 ASIA PACIFIC CGMS HOSPITALS MARKET, 2017-2025(IN US$ MILLION)
FIGURE 9 ASIA PACIFIC SMBG MARKET SHARE, BY COMPONENT TYPE 2016 & 2025(%)
FIGURE 10 ASIA PACIFIC SMBG TEST STRIPS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 11 ASIA PACIFIC SMBG GLUCOSE METER MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 12 ASIA PACIFIC SMBG OTHERS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 13 ASIA PACIFIC SMBG MARKET SHARE, BY COMPONENT TYPE 2016 & 2025(US$ MILLION)
FIGURE 14 ASIA PACIFIC SMBG HOME SETTING MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 15 ASIA PACIFIC SMBG CLINICAL MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 16 ASIA PACIFIC SMBG HOSPITALS MARKET, 2017-2025 (IN US$ MILLION)
FIGURE 18 ASIA PACIFIC GGMS MARKET SHARE, BY COUNTRY 2016 & 2025(%)
FIGURE 19 ASIA-PACIFIC CGMS MARKET REVENUE 2017-2025(US$ MILLION)
FIGURE 20 ASIA-PACIFIC CGMS MARKET SHARE, BY COUNTRY 2016 & 2025 (%)
FIGURE 21 CHINA CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
FIGURE 22 CHINA SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
FIGURE 23 INDIA CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
FIGURE 24 INDIA SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
FIGURE 25 AUSTRALIA CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
FIGURE 26 AUSTRALIA SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)
FIGURE 27 REST OF ASIA-PACIFIC CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)
FIGURE 28 REST OF ASIA-PACIFIC SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)



【レポートのキーワード】

グルコース監視システム

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ グルコース監視システムのアジア太平洋市場(Asia Pacific Glucose Monitoring System (CGMS & SMBG) Market Forecast 2017-2025)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆